Polaris AI Pharma Corp. (KOSDAQ:041910)
6,320.00
-50.00 (-0.78%)
At close: Mar 6, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 83.95 billion as of March 6, 2026. Its market cap has increased by 1.61% in one year.
Market Cap
83.95B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
74.60
Stock Price
6,320.00
Market Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 83.95B, an increase of 680.94%. That is a compound annual growth rate of 9.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 83.95B | 1.44% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 98.44B |
| Sam-A Pharm. | 96.01B |
| Daehan Nupharm | 92.07B |
| Ahn-Gook Pharmaceutical | 90.24B |
| Sinsin Pharmaceutical | 86.17B |
| Hwail Pharmaceutical | 85.51B |
| GL Pharm Tech | 84.14B |
| BL Pharmtech | 81.47B |